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Abstract
Background: The assessment of blood lipids is very frequent in clinical research as it is assumed to reflect the lipid
composition of peripheral tissues. Even well accepted such relationships have never been clearly established. This is
particularly true in ophthalmology where the use of blood lipids has become very common following recent data linking
lipid intake to ocular health and disease. In the present study, we wanted to determine in humans whether a lipidomic
approach based on red blood cells could reveal associations between circulating and tissue lipid profiles. To check if the
analytical sensitivity may be of importance in such analyses, we have used a double approach for lipidomics.
Methodology and Principal Findings: Red blood cells, retinas and optic nerves were collected from 9 human donors. The
lipidomic analyses on tissues consisted in gas chromatography and liquid chromatography coupled to an electrospray
ionization source-mass spectrometer (LC-ESI-MS). Gas chromatography did not reveal any relevant association between
circulating and ocular fatty acids except for arachidonic acid whose circulating amounts were positively associated with its
levels in the retina and in the optic nerve. In contrast, several significant associations emerged from LC-ESI-MS analyses.
Particularly, lipid entities in red blood cells were positively or negatively associated with representative pools of retinal
docosahexaenoic acid (DHA), retinal very-long chain polyunsaturated fatty acids (VLC-PUFA) or optic nerve plasmalogens.
Conclusions and Significance: LC-ESI-MS is more appropriate than gas chromatography for lipidomics on red blood cells,
and further extrapolation to ocular lipids. The several individual lipid species we have identified are good candidates to
represent circulating biomarkers of ocular lipids. However, further investigation is needed before considering them as
indexes of disease risk and before using them in clinical studies on optic nerve neuropathies or retinal diseases displaying
photoreceptors degeneration.
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Introduction
The nervous system is the organ with the second largest
concentration of lipids, only exceeded by adipose tissue. Nervous
tissues contain about 50 to 60% of their dry weight as lipids, and
approximately 35 to 40% of these lipids are polyunsaturated fatty
acids (PUFAs) [1,2,3,4]. These lipids almost exclusively consist in
PUFA-rich-membrane phospholipids and in cholesterol playing a
structural function without being related to energy metabolism [3].
As elements of the nervous system, ocular tissues such as the
optic nerve and the neural retina display similar characteristics
[5,6,7]. Phospholipids represent about two-thirds of total lipids in
these structures and are characterized by species rich in PUFAs.
Although docosahexaenoic acid (DHA; C22:6n-3) represents a
small percentage of the fatty acids in most human tissues, it is the
most abundant PUFA in the retina [7]. The highest level of DHA
in the retina is observed in the outer part of photoreceptor cells
where it plays important biophysical and biochemical functions in
visual transduction [8], and protection against cell injury [9]. Since
it is composed by myelinated axons of retinal ganglion cells, the
optic nerve is characterized by its high content in particular
phospholipids termed as ‘‘plasmalogens’’, whose concentration is
increased in myelin [3,5,10].
Ophthalmic diseases affecting the optic nerve and the retina
result in alteration of specific cell types, and obviously of the tissue
lipid molecular profile. The loss of DHA-rich photoreceptor cells
in the retina is a characteristic feature of retinal degenerations such
as age-related macular degeneration (AMD) _the leading cause of
vision loss in people aged 65 years or more in western countries
[11]_ or retinitis pigmentosa that is a group of hereditary retinal
degenerations characterized by progressive night blindness [12].
Concerning the optic nerve, glaucomatous optic neuropathy or
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glaucoma is one of the most important degenerative disease in
term of prevalence since it represents the second leading cause of
blindness worldwide by affecting more than 60 million people in
2010 [13]. Glaucoma is characterized by structural changes in the
optic nerve head and a reduction of the optic nerve diameter, due
to a loss of either axons, myelin, or both [14,15].
Results from numerous epidemiological studies have suggested
that lower dietary intakes and lower circulating concentrations of
DHA are associated with higher risk of AMD [16,17,18,19,20,21].
Several works have also shown lower levels of DHA in plasma and
erythrocytes of patients with retinitis pigmentosa [22,23,24,25].
These data led to dietary supplementation trials with DHA for
both AMD and retinitis pigmentosa [26,27,28], and to the
commercialization of DHA-rich dietary supplements in markets
[29], the objective being to maintain or to increase retinal DHA in
order to prevent these diseases. To our knowledge, only two
studies have established potential relationships between circulating
lipids and the pathogenesis of glaucoma. Both of them have
demonstrated reduced levels of DHA in plasma and red blood cells
of primary open angle glaucoma patients [30,31], together with an
additional alteration of circulating levels of plasmalogens [31].
All of these human studies that aim to characterize either
pathophysiological events occurring in the eye or the bioavailabil-
ity/efficacy of dietary treatments need valuable circulating
biomarkers in order to mirror retinal concentrations in lipids
under pathological influence or in response to a dietary
supplementation. Red blood cell membrane lipids are considered
as an index of tissue lipid status because the fatty acids they
contain are associated with structural membrane lipids [32]. Since
red blood cell lipids are also less sensitive than plasma lipids to
dietary fluctuations, another advantage is that they represent the
longer-term fatty acid status of the individual. A few number of
studies have found out some correlations between red blood cell
DHA level with DHA concentrations in neural tissues including
the retina [4,33,34]. However, these studies were exclusively
performed in models of post-natal development (rat, baboon and
human) and the authors agreed to conclude that the extrapolation
of red blood cell DHA level to that of the retina may be valid only
during development, at the time when PUFA levels increase
rapidly in neuronal tissues.
Because red blood cell fatty acid composition is a commonly
used biomarker in human studies, the aim of our work was to
check the validity of its use in adult humans for ocular tissues. For
that purpose, we have investigated the possible associations
between erythrocytes and retina/optic nerve lipids in tissues
collected from human donors. The lipidomic analyzes were done
through a double analytical approach, the standard and
commonly-used gas chromatography methodology and the more
specific liquid chromatography coupled to an electrospray
ionization source-mass spectrometer (LC-ESI-MS).
Methods
Ethics Statement
Collection of the samples from human deceased subjects was
conducted in accordance with the guidelines of the Declaration of
Helsinki. A written consent was obtained and the protocol was
accepted by the local ethics committee (CPP Sud Est I, CHU Saint
Etienne, Saint Etienne, France).
Human tissues
Human eyeballs and erythrocytes were obtained from 9 donors
(bodies donated to science, 5 women and 4 men, mean age
84.368.5 years, range 72–97 years, Table 1), within 16 h
(median time, mean time 1567 h) after death. The bodies were
refrigerated at +4uC in the first hours after death (less than 24 h).
A blood sample was collected in heparinized tubes by venipunc-
ture. Red blood cells were separated from plasma by centrifuga-
tion at 3000 rpm for 10 min at +4uC. Eyeballs were enucleated at
the anatomy laboratory of the Saint Etienne School of Medicine
(France). Enucleated eyeballs were immersed in a balanced saline
solution (BSS, Alcon, Rueil Malmaison, France) at +4uC. Within
30 min after enucleation, a circular section at the pars plana was
taken with a 18-mm diameter trephine and the corneoscleral disc
was removed for other studies. The posterior pole of the eyeball
was placed on a back-lit table and the retina was observed under
an operating microscope to select the tissues further included in
this study. No eye having large drusen, severe pigment epithelial
alterations, severe macular atrophy, macular hemorrhage, or any
grossly visible chorioretinal pathologic abnormality was included
in the study. Moreover, a gross examination of the optic nerve
Table 1. Characteristics of the human donors, tissue collection, and sample analyzes.
subject gender age post mortem delay before tissue collection Collected tissues LC-ESI-MS analyzes
#1 female 82 15.0 erythrocytes, retina PC, PE
#2 male 97 9.5 erythrocytes, retina, optic nerve PC, PE$
#3 male 72 24.0 erythrocytes, retina, optic nerve PC, PE
#4 female 82 7.0 erythrocytes, retina, optic nerve PC, PE
#5 female 88 6.5 erythrocytes, retina PC
#6 male 90 14.0 erythrocytes, retina PC
#7 male 75 21.0 erythrocytes, retina, optic nerve PC
#8 female 94 23.5 erythrocytes, retina, optic nerve PC
#9 female 79 24.0 erythrocytes, retina, optic nerve PC, PE
mean ± SD* - 84.368.5 16.167.3 - -
median - 82.0 15.0 - -
range - 72–97 6.5–24.0 - -
*: Standard Deviation.
$: no data for retinal PE for this subject.
doi:10.1371/journal.pone.0035102.t001
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head did not reveal any case of Glaucoma within the donors. The
vitreous body was carefully removed. The entire neural retina
(n = 9) was carefully separated from the RPE/choroid with
forceps. The optic nerves (n = 6) were excised by cutting tangential
to the sclera after having removed the extraocular tissues. All
samples were immediately stored at 280uC until further analyses.
Lipid analyses
All chemical reagents were purchased from Sigma-Aldrich (St
Quentin Fallavier, France), chloroform and methanol from SDS
(Peypin, France). HPLC-grade N-hexane, chloroform and isopro-
panol, LC-MS-grade methanol and water were all from Fisher
Scientific (Illkirch, France). All phospholipid standards were
obtained from Avanti Polar Lipids Inc. (Alabaster, AL, USA).
Lipid extraction from human tissues. Lipids were
extracted from the retinas and optic nerves following the Folch’s
procedure [35] whereas they were isolated from erythrocytes
according to the method of Moilanen and Nikkari [36].
Phospholipids were purified from total lipid extracts using silica
cartridges (25610 mm i.d.; Sep-pack, Waters S.A., Framingham,
MA, USA), as previously described by our group [31,37].
Phospholipid extracts were stored under inert gas until further
analyses.
Fatty acid analysis by gas chromatography. Total
phospholipids from neural retina, optic nerve, and red blood
cells were transmethylated using boron trifluoride in methanol
according to Morrison and Smith [38]. Fatty acid methyl esters
(FAMEs) and dimethylacetals (DMAs) were subsequently extracted
with hexane and analyzed by gas chromatography on a Hewlett
Packard Model 5890 gas chromatograph (Palo Alto, CA, USA)
using a CPSIL-88 column (100 m60.25 mm i.d., film thickness
0.20 mm; Varian, Les Ulis, France) equipped with a flame
ionization detector. Hydrogen was used as the carrier gas (inlet
pressure 210 kPa). The oven temperature was held at 60uC for
5 min, increased to 165uC at 15uC/min and held for 1 min, and
then to 225uC at 2uC/min and finally held at 225uC for 17 min.
The injector and the detector were maintained at 250uC. FAMEs
and DMAs were identified by comparison with commercial and
synthetic standards. The data were processed using the EZChrom
Elite software (Agilent Technologies, Massy, France) and reported
as a percentage of the total fatty acids.
Structural analysis of phospholipids by LC-ESI-
MS. Prior to LC-ESI-MS analyses, the phosphorus content of
the total phospholipid extract was determined according to the
method developed by Bartlett and Lewis [39]. The total
phospholipids were dried under nitrogen, and internal standards
dimyristoyl-sn-glycerol-3-phosphatidylethanolamine (PE14:0/
14:0, final concentration of 0.2 ng/mL) and dimyristoyl-sn-
glycerol-3-phosphatidylcholine (PC14:0/14:0, final concentration
of 0.4 ng/mL) were added. The samples were diluted at a final
concentration of 12.5 ng/mL in chloroform/methanol (1:1, v/v)
for analysis and stored at 280uC under argon atmosphere.
The total phospholipids were analysed by liquid chromatogra-
phy coupled to a mass spectrometer equipped with an ESI source.
Liquid chromatography was performed using a Jasco PU 2089
Plus LC pump equipped with a Jasco AS 2057 Plus auto-sampler
(Jasco Analytical Instruments, Bouguenais, France). The injection
volume was of 5 mL. The separation was performed using a
Hypersil Gold Silica Column (150 mm62.1 mm i.d. 63 mm,
ThermoFinnigan, San Jose, CA, USA). The mobile phase
consisted of (A) hexane/propan-2-ol/chloroform/water (44/
43.5/10.5/2, v/v/v/v) containing 12.5 mM of ammonium
formate and (B) hexane/propan-2-ol/chloroform/water (34/49/
10.5/6.5, v/v/v/v) containing 12.5 mM of ammonium formate.
The solvent-gradient system was as follows: 0 min A/B (%) 100/0,
10.5–24 min A/B (%) 22/78, 26.5–45 min A/B (%) 0/100% and
46–60 min A/B (%) 100/0. The flow rate was 300 mL.min21 and
the column was maintained at 30uC. The flow from LC was split
using an analytical fixed flow splitter (split ratio = 1:1, post-column,
Analytical Scientific Instruments, El Sobrante, CA, USA). Mass
spectrometry was performed using a ThermoFinnigan TSQ
Quantum triple quadrupole mass spectrometer equipped with a
standard electrospray ionisation source outfitted with a 100-mm
i.d. H-ESI needle. The source spray head was oriented at a 90u
angle orthogonal to the ion-transfer tube. Nitrogen was used for
both the sheath and the auxiliary gases. The MS signals of
phosphatidyl-choline species (PC) were first optimised by contin-
uous infusion of the standards dissolved in the mobile phase using
ESI in negative and positive modes. The electrospray ionisation
spray voltages were 3 kV and 24.5 kV in negative and positive
ion modes, respectively. The vaporiser temperature was of 150uC,
sheath gas N2 pressure 45 (arbitrary units), auxiliary gas pressure
45 (arbitrary units), ion sweep gas pressure 5, ion transfer capillary
temperature 300uC, skimmer offset 5 V and multiplier gain
300,000.
When operated under full scan conditions in the negative and
positive ion modes, data were collected in the range of m/z 400–
1100 amu with a scan time of 0.5 s. For PC characterization in the
negative mode, ESI-MS/MS was used with argon as the collision
gas at 1.5 mTor, and the collision energy was set to 15 eV; in the
positive mode, the collision gas pressure was 0.8 mTor and the
collision energy ranged from 30 to 45 eV. Phosphatidyl-ethanol-
amine (PE) and PC species were manually identified with the
parent mass information and their characteristic fragment ions in
the CID spectrum using lists of phospholipid species from our
laboratory [31,40].
Upon CID in the positive mode, PC and choline-plasmalogen
species (plasmenyl-choline, PlsC) showed an intense fragment at
m/z 184 amu due to their common choline head group. This
fragment at m/z 184 amu was used for precursor ion scanning,
whereby the [M+H]+ ions of PCs are specifically detected and
quantified. For all calculations, the ratio of peak area of each PC
species to the peak area of the internal standard (PC14:0/14:0) was
used. Upon CID in the positive mode, [M+H]+ ions of PE loose
their ethanolaminephosphate head group as a neutral fragment of
141 Da. Therefore, positive-ion mode neutral loss scanning of 141
Da was used for the selective detection and quantification of PE.
For all calculations, the ratio of peak area of each PE species to the
peak area of the internal standards (PE14:0/14:0) was used.
During the quantification step, a particular attention was paid
to the influence of different parameters related to PE and PC acyl-
chain length, degree of acyl-chain unsaturation on spectrometer
response according to previous studies [40,41,42,43]. Thus the
relationship between the MS peak intensities of different PC
species and their carbon chain length was included for calibration
as described in our previous work [40]. Concerning PE species,
similar precautions were taken in this quantitative study because
different PE molecular species are not detected with equal
efficiency response. Moreover, previous studies indicated that the
total phospholipid concentration affect the quantification of PE
species by ESI-MS/MS [44]. Therefore, we investigated the
influence of these different parameters on the instrument response.
First, to establish the range of linear response of our ESI-MS/MS
instrument, an equimolar mixture was prepared with standards of
PE14:0/14:0, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(PE16:0/16:0), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethano-
lamine (PE16:0/18:1), 1,2-distearoyl-sn-glycero-3-phosphoethano-
lamine (PE18:0/18:0), 1,2-dioleoyl-sn-glycero-3-phosphoethanola-
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mine (PE18:1/18:1), 1,2-dilinoleoyl-sn-glycero-3-phosphoethano-
lamine (PE18:2/18:2), 1-stearoyl-2-arachidonoyl-sn-glycero-3-
phosphoethanolamine (PE18:0/20:4), 1-stearoyl-2-docosahexae-
noyl-sn-glycero-3-phosphoethanolamine (PE18:0/22:6), and 1,2-
didocosahexaenoyl-sn-glycero-3-phosphoethanolamine (PE22:6/
22:6) diluted from 10 pg/mL to 2 ng/mL per species (from
90 pg/mL to 18 ng/mL of total PE) in chloroform/methanol
(1:1) and then injected in the LC-ESI-MS instrument. The PE
mixture had a linear response of ion count versus concentration in
this range of concentration. Furthermore we have established a
calibration curve between the intensity of the observed quasi-
molecular ion species and the length and degree of unsaturation of
the carbon chains. Linear response curves were obtained with
increased concentrations of PE16:0/16:0, PE16:0/18:1, 1-stear-
oyl-2-linoleoyl-sn-glycero-3-phosphoethanolamine (PE18:0/18:2),
PE18:0/18:0, PE18:0/20:4, PE18:0/22:6, 1,2-eicosanoyl-sn-gly-
cero-3-phosphoethanolamine (PE20:0/20:0) and PE22:6/22:6
(range, 10 pg/mL to 2 ng/mL) and fixed concentrations of
PE14/14:0 (0.2 ng/mL). Our results confirmed that the instrument
response for PE species decreases when the phospholipid acyl
chain length is increased. The responses remain a linear function
of the acyl chain length, even at the highest concentrations. Thus,
similarly to PC, a calibration function was then calculated and
used to correct the experimental ion abundance in order to obtain
the true molar abundance.
Since the use of the neutral loss of 141 Da is problematic in the
quantification of ethanolamine-plasmalogen species (plasmenyl-
ethanolamine, PlsE) [45], the method was based on multiple
reaction monitoring (MRM) of one parent/fragment transition for
each selected plasmalogen and PE14:0/14:0 as internal standard.
For example, the MS2 fragmentation of the selected molecular ion
[M-H]2 at m/z 728 amu of commercial 1-(1Z-octadecenyl)-2-
oleoyl-sn-glycero-3-phosphoethanolamine (PlsE18:0/18:1) showed
a principal fragment [R2CH2COO]
2 resulting from the loss of the
sn-2 acyl group: m/z 281 amu, which corresponds to oleic
carboxylate. Thus, PlsE18:0/18:1 was quantified using the specific
transition 728 R 281 amu. The method was then optimized on
the specific transition parent/fragment of the two other commer-
cial PlsE standards 1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-
3-phosphoethanolamine (PlsE180/20:4, 750 R 303 amu) and 1-
(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphoethano-
lamine (PlsE180/22:6, 774 R 327 amu) in addition to PlsE18:0/
18:1 (728R281 amu) and PE14:0/14:0 (634 R 227 amu). Linear
response curves were obtained with increased concentrations of
PlsE180/18:1, PlsE180/20:4 and PlsE180/22:6 (range 10 pg to
2 ng/mL per species) and fixed concentrations of PE14:0/14:0
(0.2 ng/mL). The standard curves were plotted as the ratio height
of the respective compound/height of PE14:0/14:0 versus the
concentration. Considering that all PlsE have the same basic
chemical structure and differ only by different fatty acid side
chains and that the principal fragment is the sn-2 fatty acid, the
theoretical LC-MS/MS parent fragments transitions of PlsE were
determined. The data were processed using the Xcalibur software
(ThermoFinnigan). Corrections were applied to the data for
isotopic overlap.
Statictical analyses
The data were analyzed using SAS software (SAS Institute,
Cary, NC, USA). The non-parametric Spearman correlation
coefficients were calculated to determine associations between
tissue profiles. Associations were considered significant at a P level
of less or equal to 0.05.
Results
The characteristics of the human donors and of the studied
samples are presented in Table 1. Nine human donors were
included in this study. Five of them were females, and 4 were
males. The median age of the donors was of 82 years (mean6 SD:
84.368.5 years). Erythrocytes and retinas were collected from all
human donors whereas optic nerves were obtained from 6 subjects
(3 females and 3 males). The median post-mortem delay for tissue
collection was of 15 hours (mean 6 SD: 16.167.3 hours), with a
maximum time of 24 hours for two of the donors. Previous results
from our laboratory have shown that even a mean post-mortem
delay of 34 hours do not enhance the degradation of tissue lipids,
as shown by the absence of free fatty acids and the lack of negative
association between retinal DHA and post-mortem delay [46].
Fatty acid compositions and associations emerging from
standard gas chromatographic analyses
Fatty acid composition. Gas chromatography gave an
overview of the relative abundance of FAMEs and DMAs.
FAMEs are formed by transmethylation of acyl- moieties issued
from conventional phospholipids and plasmalogens whereas
DMAs are from alkenyl- moieties issued from plasmalogens only
(Figure 1) [38].
The complete fatty acid composition of erythrocytes, retinas and
optic nerves obtained by standard gas chromatography is available
in Table 2. It confirmed earlier observations on human retinas
[32,46], and erythrocytes [46]. To our knowledge, no previous
data was available on the fatty composition of human optic nerve.
The erythrocytes were characterized by high levels of palmitic acid
(C16:0), stearic acid (C18:0), oleic acid (C18:1n-9), linoleic acid
(C18:2n-6), and arachidonic acid (C20:4n-6). PUFAs from the
omega-3 family were present at lower levels, the most abundant
being DHA at a median level of 3.46% of total FAMEs + DMAs.
Whereas C16:0, C18:0, C18:1n-9, and C20:4n-6 were also present
at high levels in the retina, the amount of C18:2n-6 was lower
(median value of 1.49% of total FAMEs + DMAs) and those of
DHA were higher (median value of 15.03% of total FAMEs +
DMAs) when compared to erythrocytes. As described previously
[46], the inter-individual differences were low for the retina except
for DHA (CV=17.4%, range: 10.96–19.15% of total FAMEs +
DMAs). The optic nerve was characterized by very high levels of
C16:0, C18:0, and C18:1n-9 (median values of 14.87%, 13.90%,
and 25.39%, of total FAMEs + DMAs, respectively). The levels of
C20:4n-6 and DHA were low since their median values did not
exceed 4.85% and 1.39% of total FAMEs + DMAs, respectively.
The most specific feature of the optic nerve was its high content in
DMAs when compared to the other tissues. Since the percentage
of DMAs is known to reflect the half of the plasmalogen pool [47],
plasmalogens account for about 36% of the phospholipids in the
optic nerve whereas they represent about 9 to 10% in both
erythrocytes and retinas.
Associations between circulating and ocular
concentrations. The complete list of statistically significant
associations emerging from gas chromatographic analyzes between
erythrocyte and retinal/optic nerve fatty acids is presented in
Table 3. No association was found between erythrocyte DMAs
and retinal DMAs. However, DMA18:1n-9 and DMA18:1n-7 in
erythrocytes were positively associated with a-linolenic acid
(C18:3n-3) and C20:4n-6 (rSpearman=0.848, P,0.01 and
rSpearman=0.756, P=0.02, respectively) and C20:4n-6
(rSpearman=0.671, P=0.04) in the retina, respectively. C20:4n-6
in erythrocytes was positively associated with retinal C20:4n-6
(rSpearman=0.833, P=0.02) (Figure 2), and negatively associated
Circulating Biomarkers of Ocular Lipids in Human
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with DHA in the retina (rSpearman=20.867, P,0.01). Retinal
individual n-3 PUFAs were negatively associated not only with n-6
PUFAs but also with other individual n-3 PUFAs in erythrocytes.
This was particularly true for retinal DHA, whose level was
negatively related to those of n-6 docosapentaenoic acid (C22:5n-
3) and C22:6n-3 in erythrocytes (rSpearman=20.900, P,0.001
and rSpearman=20.733, P=0.02, respectively; Figure 2). No
significant association was found between erythrocyte and retinal
n-6/n-3 ratios (rSpearman=20.493, P=0.18).
As observed for the retina, no association was found between
optic nerve DMAs and erythrocyte DMAs (Figure 2). Erythrocyte
DMA16:0 and DMA18:1n-9 were positively associated with optic
nerve C20:4n-6 (rSpearman=0.863, P=0.02 and rSpearman=0.840,
P=0.03, respectively). Erythrocyte DMA18:1n-7 was positively
associated with optic nerve C18:2n-6 (rSpearman=0.771, P=0.04).
The remaining statistically significant associations between
erythrocytes and optic nerve concerned almost exclusively n-6
PUFAs in erythrocytes. These ones were either positively
associated with n-6 PUFAs, or negatively associated with n-3
PUFAs in the optic nerve. Indeed, C20:4n-6 and eicosadienoic
acid (C20:2n-6) in erythrocytes were positively associated with
C20:4n-6 and n-6 docosatetraenoic acid (C22:4n-6) in the optic
nerve, respectively (rSpearman=0.828, P=0.04 and rSpear-
man=0.943, P,0.01, respectively) (Figure 2) whereas C18:3n-6
and n-6 eicosatrienoic acid (C20:3n-6) in erythrocytes were
negatively associated with total n-3 PUFAs and DHA in the optic
nerve. No significant association was found between C20:4n-6 in
erythrocytes and DHA in the optic nerve.
Concentrations of individual phospholipid species and
associations emerging from LC-ESI-MS analyzes
Separation of phospholipids by LC. We have chosen to
separate the phospholipid species using LC prior to the ESI-MS/
MS analysis in order to enhance the detection of the minor
isobaric species in the mixture. During the development of LC
separation of total phospholipids, the mass spectrometer was
operated under full scan conditions in the negative ion mode for
detection of PE, phosphatidyl-inositol (PI), phosphatidyl-serine
(PS) and lyso-phosphatidyl-ethanolamine (LPE) and under full
scan conditions in the positive ion mode for quantification of PC,
lyso-phosphatidyl-choline (LPC) and sphingomyelin (SM) species
[40]. Successful separation of PE, PI, PS, PC, LPC, and SM was
achieved using a silica gel column and a gradient of hexane/
isopropanol/water containing ammonium formate as a mobile
phase. Individual phospholipid classes were identified by
comparing their retention volume and mass spectra to those of
their corresponding standards (Figure 3). As expected, PlsE and
PlsC species coeluted with PE and PC species, respectively. Under
our HPLC conditions, PC species containing very long chain
polyunsaturated fatty acids (VLC-PUFAs) eluted separately just
prior to the other PC molecular species in the retina.
Characterization and quantification of PE, PlsE, PC and
PlsC species. A complete structural characterization of intact
PE, PlsE, PC, and PlsC species including plasmalogens was
obtained from human neural retina, optic nerve and red blood
cells using electrospray tandem mass spectrometer (ESI-MS/MS)
by collision-induced dissociation (CID) in the negative mode. Fatty
acid composition and distribution have been clearly assigned based
on the intensity of sn-2/sn-1 fragment ions as Figure 4 shows
HPLC-ESI-MS mass spectra of total PC and PE fractions after the
addition of the internal standard.
The complete composition in individual species of PC and PlsC
in erythrocytes, retinas and optic nerves is available in Table S1.
Briefly, total choline-phospholipids (PC+PlsC) represented about
375, 490 and 390 mg per milligram of total phospholipids in
erythrocytes, retinas, and optic nerve, respectively, thus confirm-
ing earlier observations having estimated these levels to be of 36%,
48%, and 40%, respectively [5,7,32]. The most represented
species in all of the studied tissues was PC16:0/18:1. The retina
was characterized by the presence of species with fatty acids
having more than 30 carbon atoms, so called ‘‘very-long-chain
PUFA’’ (VLC-PUFA), whereas the optic nerve contained species
with VLC-PUFAs having 24 to 26 carbon atoms.
Figure 1. Structure of conventional phospholipids and plasmalogens. Conventional phospholipids such as phosphatidyl-choline and
phosphatidyl-etanolamine contain ester bonds in order to link R1 and R2 acyl- moieties at the sn-1 and sn-2 positions of glycerol, respectively. As for
ethanolamine- and choline- plasmalogens, they have a vinyl ether bond at the sn-1 position of the glycerol backbone to link alkenyl- moieties and an
ester bond at the sn-2 position to link acyl- residues.
doi:10.1371/journal.pone.0035102.g001
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Table S2 describes the concentrations in all individual species
of PE and PlsE in erythrocytes, retinas and optic nerves. The
erythrocyte content in PE was of 145 mg per milligram of total
phospholipids, which is in agreement with the literature having
estimated it to be of 19% [32]. So was that of the optic nerve with
a mean concentration of 141 mg per milligram of total phospho-
lipids when compared to previous observations having described
values of 8.7% and 11.7% in samples from rabbit and bovine
origin, respectively [5,6]. The retinal content in PE showed more
variability as confirmed by the large range of concentrations (from
292 to 608 mg per mg of total phospholipids). This may explain the
higher mean value we have measured (400 mg per mg of total
phospholipids) when compared to previous data from us or others
showing that total PE species represent 29.5% and 31.7% of total
phospholipids in bovine and human retinas, respectively [7,47].
Within the three tissues studied, the retina was characterized by its
high content in PE species esterified with DHA, representing
almost 65% by mean of total PE species.
Associations between circulating and ocular
concentrations of PC and PlsC. The complete list of
statistically significant associations between erythrocyte and
retinal PC and PlsC is presented in Table 4. PC species with
saturated or monounsaturated fatty acids in erythrocytes (PC14:0/
16:0 and PC16:0/16:0) were negatively associated with other
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Table 3. Statistically significant associations between
erythrocyte and optic nerve or retinal phospholipid fatty acid
compositions evaluated by gas chromatography.
erythrocyte retina optic nerve
rSpearman P rSpearman P
DMA16:0a no association C20:4n-6 0.863 0.02
DMA18:0 no association no association
DMA18:1n-9 C18:3n-3
C20:4n-6
0.848
0.756
,0.01
0.02
C20:4n-6 0.840 0.03
DMA18:1n-7 C20:4n-6 0.671 0.04 C18:2n-6 0.771 0.04
total DMA no association no association
C18:2n-6 no association no association
C18:3n-6 no association total n-3
n-6/n-3
20.815
1.000
0.01
,0.0001
C20:2n-6 no association C22:4n-6 0.943 ,0.01
C20:3n-6 C20:5n-3 20.740 0.02 C22:6n-3
total n-3
20.985
20.927
,0.01
,0.01
C20:4n-6 C20:4n-6
C22:6n-3
0.833
20.867
,0.01
,0.01
C20:4n-6 0.828 0.04
C22:4n-6 C22:6n-3 20.667 0.04 no association
C22:5n-6 no association no association
total n-6 total n-3
n-6/n-3
20.658
0.616
0.05
0.04
no association
C18:3n-3 no association no association
C20:5n-3 no association C22:5n-6 20.880 0.02
C22:5n-3 C22:6n-3 20.900 ,0.001 no association
C22:6n-3 C22:6n-3 20.733 0.02 no association
total n-3 total PUFA 20.883 ,0.01 no association
n-6/n-3 total PUFA 0.867 ,0.01 no association
total PUFA no association no association
a: corresponding to the derivative formed during methylation from alkenyl-
residues of plasmalogens.
doi:10.1371/journal.pone.0035102.t003
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species with saturated and/or monounsaturated fatty acids in the
retina. Other erythrocyte PC species (namely PC18:0/22:6 and
PC20:6/22:6) were positively associated with other PC species
containing DHA in the retina (PC18:1/22:6, PC22:6/22:6, and
PC24:5/22:6). Finally, the most interesting result concerned
PC16:0/20:4 in erythrocytes, which was negatively associated
with PC species containing together DHA and VLC-PUFAs
having more than 30 carbon atoms (PC30:0/22:6,
rSpearman=20.650, P=0.05; PC34:6/22:6, rSpearman=20.660,
P=0.05; PC36:6/22:6, rSpearman=20.716, P=0.02, and
PC36:5/22:6, rSpearman=20.717, P=0.02). The retinal species
containing DHA concerned only PC but not PlsC species. DHA-
rich PC represented 11.2% of total choline-phospholipids and
were esterified or not with VLC-PUFAs (Figure 5A). PC having
VLC-PUFAs accounted for of 25.7% total PC with DHA.
Fourteen PC species containing VLC-PUFAs were identified
and quantified in the retina (Figure 5B). The longest and most
unsaturated ones, namely PC34:6/22:6, PC36:6/22:6, and
PC36:5/22:6, accounted for 22.7% of retinal VLC-PUFAs.
Taken together, these three entities were negatively associated
with PC16:0/20:4 in erythrocytes from human donors
(rSpearman=20.783, P=0.01, Figure 5C).
The complete inventory of statistically significant associations
emerging from LC-ESI-MS analyzes of erythrocyte and optic
nerve PC and PlsC is presented in Table 5. Within the 13
statistically significant associations found, 8 concerned plasmalo-
gen species. Six of these entities were PlsC species with saturated,
monounsaturated or polyunsaturated with 2 or three double bonds
fatty acids in erythrocytes (namely PlsC16:0/16:1, PlsC18:1/18:0,
PlsC18:0/18:0, PlsC18:1/20:2, PlsC18:0/20:3, and PlsC18:1/
22:1) that were positively associated with other PlsC species having
saturated or monounsaturated fatty acids in optic nerve. The
remaining species were PlsC18:0/22:4 and PlsC18:1/22:4 whose
concentrations in erythrocytes were positively associated to other
PlsC species in the optic nerve. Concerning the concentrations of
non-plasmalogen phospholipids in erythrocytes, they were nega-
tively associated to those from the optic nerve. Within the several
species found to display statistically significant associations,
PC18:0/20:2 was particularly interesting since it was negatively
associated with several PC species having VLC-PUFA with 22 to
25 carbon atoms and DHA at sn-1 and sn-2 positions of glycerol,
respectively (PC22:3/22:6, rSpearman=20.767, P=0.04; PC22:2/
22:6, rSpearman=20.822, P=0.02; PC24:3/22:6, rSpear-
man=20.942, P,0.01, PC25:6/22:6, rSpearman=20.837,
P=0.01; and PC25:3/22:6, rSpearman=20.942, P,0.01).
Associations between circulating and ocular
concentrations of PE and PlsE. The inventory of statistically
significant associations between erythrocyte and retinal PE and
PlsE is presented in Table 6. As for PC species, PE species with
saturated or monounsaturated fatty acids in erythrocytes (PE16:0/
16:0 and PC18:0/18:1) were positively associated with other
species with saturated and/or monounsaturated fatty acids in the
retina. Other PC entities having saturated or monounsaturated
fatty acids at sn-1 and polyunsaturated fatty acid at sn-2 (namely
PE16:0/18:2, PE18:0/18:2, and PE20:1/22:6) were positively
associated with PE species esterified to DHA in the retina.
PlsE18:0/20:4 was interesting since its concentrations in
erythrocytes were negatively associated with those of three major
retinal PE species esterified to DHA, namely PE20:3/22:6
(rSpearman=20.991, P,0.01), PE18:0/22:6 (rSpearman=20.973,
Figure 2. Selected significant associations between erythrocyte and retinal or optic nerve lipids after gas chromatographic
analyses. Erythrocyte arachidonic acid (C20:4n-6) was positively associated with retinal C20:4n-6 (rSpearman= 0.833, P,0.01) and optic nerve
C20:4n-6 (rSpearman = 0.828, P = 0.04). Erythrocyte docosahexaenoic acid (C22:6n-3, DHA) was negatively associated with retinal DHA
(rSpearman=20.733, P= 0.02) whereas no significant association emerged between erythrocyte and optic nerve levels of plasmalogens (evaluated
by dimethylacetals, DMA).
doi:10.1371/journal.pone.0035102.g002
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P=0.03), and PE18:1/22:6 (rSpearman=20.977, P=0.02). Taken
together, these three retinal PE species represent about 79% of
total retinal PE species with DHA, themselves accounting for
63.5% of total retinal PE (Figure 6A). When considering these
three species together as a ‘‘pool of retinal DHA’’, the negative
association with erythrocyte PlsE18:0/20:4 was still significant
(rSpearman=21.000, P,0.0001 Figure 6B).By the same way, the
concentrations of other PE entities in erythrocyte were associated
to another subsequent pool of DHA-containing PE species.
Indeed, the erythrocyte levels of PE18:0/22:4 were positively
associated with those of retinal concentrations of PE16:0/22:6
(rSpearman=0.972, P=0.03), PE18:1/22:6 (rSpearman=0.977,
P=0.02), and PE18:0/22:6 (rSpearman=0.978, P=0.02), this
group representing 88.9% of total PE species with DHA. The
positive association between erythrocyte PE18:0/22:4 and this
group was also significant when these three entities were
considered together (rSpearman=0.950, P=0.04 Figure 6C).
The same pool of DHA-rich retinal PE (namely PE16:0/22:6,
PE18:0/22:6, and PE18:1/22:6) was also positively associated with
erythrocyte PE18:0/20:4 and PE18:0/22:5, when considered
together (rSpearman=20.995, P=0.01 Figure 6C).
The list of statistically significant associations emerging from
LC-ESI-MS analyzes of erythrocyte and optic nerve PE and PlsE
is presented in Table 7. One PE specie esterified with DHA in
erythrocytes were positively associated with other PE species with
DHA in the optic nerve (PE18:0/22:6 with PE18:1/22:6, rSpear-
man=0.948, P=0.04). The circulating amounts of PE18:1/22:4
and/or PE16:0/22:5 were positively associated with the optic
nerve concentrations of several PE species esterified with
monounsaturated or polyunsaturated fatty acids (PE16:0/16:1,
rSpearman=0.988, P=0.01; PE16:0/20:4, rSpearman=0.950,
P=0.05; PE18:0/20:4, rSpearman=0.950, P=0.04; and PE18:1/
22:6, rSpearman=0.978, P=0.02). The concentrations of the other
PE species in erythrocytes (PE18:1/18:1 and/or PE18:0/18:2,
PE18:1/20:4 and/or PE16:0/22:5, PE18:0/20:4, and PE20:0/
20:3 and/or PE22:1/18:2) were negatively associated with PlsE
species in the optic nerve (PlsE16:0/20:4, PlsE18:1/20:4,
PlsE18:0/22:5, PlsE18:1/22:4, and PlsE18:0/22:6). Two circulat-
ing PlsE species, namely PlsE16:0/22:4 and PlsE16:0/22:6, were
associated with six species of PlsE in the optic nerve. When
considering the major five of them, namely PlsE16:0/20:3,
PlsE16:0/20:4, PlsE18:0/20:4, PlsE16:0/22:4, and PlsE18:0/
22:5, they represent almost 20% of the total optic nerve PlsE
(Figure 7A). This pool of optic nerve PlsE was negatively
associated with erythrocyte PlsE16:0/22:4 and PlsE16:0/22:6
considered together (rSpearman=0.988, P,0.001.
Discussion
Fatty acids are essential constituents of cell membranes where
they play multiple functions that are crucial for cell homeostasis
[3,7,48,49,50]: i) as they are almost exclusively esterified to
membrane phospholipids, they provide a structural support,
protection, and stability to the cell, ii) together with other lipid
entities such as cholesterol, they control membrane fluidity, and
subsequently they influence the functioning of specific membrane
Figure 3. LC-ESI-MS normal-phase chromatogram of the lipid extract from human retina. The retention times of phosphatidyl-
ethanolamine (PE), phosphatidyl-inositol (PI), phosphatidyl-serine (PS), phosphatidyl-choline (PC), sphingomyelin (SM), and lyso-phosphatidyl-choline
(LPC) classes were of 7–8.5 min, 11–12 min, 12–14 min, 15.5–22 min, and 23–27.5 min, respectively. The mass spectrometer was operated under full
scan in the negative ion mode from 0 to 15 min and in the positive ion mode from 15 min to 40 min.
doi:10.1371/journal.pone.0035102.g003
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Figure 4. Positive-ion HPLC-ESI-MS Mass spectra of total phosphatidyl-choline fraction collected from human neural retina. A.) optic
nerve (B.) and red blood cells (C.), by scanning for precursors at m/z 184 amu in the positive mode. Positive-ion HPLC-ESI-MS Mass spectra of total PE
fraction collected from human neural retina D.), optic nerve (E.) and red blood cells (F.), using neutral loss scan at 141 amu in the positive mode.
doi:10.1371/journal.pone.0035102.g004
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proteins involved in intra- or inter-cellular signalisation as well as
in the control of the flow of molecules into and out of the cell; and
iii) when released by specific phospholipases, they represent
powerful second messengers that are further involved in
intracellular signal transduction. The essential roles played by
fatty acids in cell membranes make that any quantitative or
qualitative modification in tissue fatty acid composition can result
in alteration of tissue and/or organ functioning. Therefore, the
monitoring and the understanding of tissue fatty acid compositions
appears to be essential, particularly in organs where these lipids
are known to exert specific fundamental functions such as the
brain, the eye, and the heart. Since access to such tissues is limited
in humans, intermediate biomarkers of these lipids are needed.
This is probably why the measurement of the blood lipid
composition has become very common in human nutrition
research as an index of the dietary fat intake but also as a
biomarker of a disease risk.
Within the blood compartment, the lipid composition of plasma
has often been used in human studies to consider the overall lipid
status of individuals. As well described in a number of good
reviews [51,52,53,54], the idea behind that was that the fatty acid
composition of a specific tissue would follow the same pattern than
that of plasma. However, although plasma lipids might reflect the
lipid status of other tissues, the fatty acid composition of plasma is
also known to represent also the endogenous processing of lipids as
well as their recent dietary intake [55,56,57,58]. Moreover, the
relationship between dietary lipids, plasma lipids and tissue
concentrations in lipids was found to be non-linear and modulated
by several other factors such as genetics, age, gender, and
oxidative stress generated by life style (smoking, alcohol consump-
tion, physical activity) [59,60,61,62,63,64]. Even if they were not
used routinely in a large number of studies, erythrocytes appear to
be a good alternative to plasma for the measurement of circulating
fatty acids since red blood cell lipids are less prone to external
influence. Indeed, it is commonly said that the erythrocyte fatty
acid composition is more representative than plasma for the long-
term dietary intake in lipids [51,65,66], due to a life span of
approximately 120 days [67]. Fatty acid composition of erythro-
cytes was used in a few number of human studies, particularly to
assess the incorporation of dietary lipids into the blood
compartment, and their bioavailability to peripheral tissues
[4,68,69,70,71,72,73,74,75,76,77]. Among them, a study of
Makrides and collaborators has examined the fatty compositions
of the brain, the retina, and the erythrocytes from post-mortem
infants [4]. By gas chromatographic analyses, the authors have
shown that erythrocyte levels of DHA were positively correlated to
those of the brain, the retina having not been involved in the
regression analyses. Such gas chromatographic data was also
Table 4. Statistically significant associations between erythrocyte and retinal individual choline-phospholipid concentrations
evaluated by liquid chromatography coupled with tandem mass spectrometry.
erythrocytes retina
molecular species [M+H]+
range of concentration
(mg of mg phospholipids) molecular species [M+H]+
range of concentration
(mg of mg phospholipids) rSpearman P
PC14:0/16:0a 706.50 1.36–3.91 PC16:0/18:0 762.59 21.33–27.88 20.610 0.05
PC18:1/18:1 786.59 8.56–15.16 20.736 0.02
PC16:0/16:0 734.56 6.15–25.48 PC16:1/16:1 730.53 1.08–2.29 20.633 0.05
PC16:0/18:1 760.58 147.15–175.04 20.697 0.02
PC16:0/18:0 762.59 21.33–27.88 20.626 0.05
PC18:1/18:1 786.59 8.56–15.16 20.754 0.01
PC18:0/18:1 788.61 29.79–44.54 20.713 0.02
PC14:0/22:5 780.50 1.00–5.88 PC16:0/22:5 808.58 6.72–10.07 0.724 0.01
PC36:5/22:6 1076.90 0.18–0.88 0.636 0.04
PC16:0/20:4 782.56 14.79–28.12 PC30:0/22:6 1002.70 0.05–0.50 20.650 0.05
PC34:6/22:6 1046.80 0.06–3.02 20.660 0.05
PC36:6/22:6 1074.80 0.38–1.58 20.716 0.02
PC36:5/22:6 1076.90 0.18–0.88 20.717 0.02
PC18:1/18:2 784.58 7.42–16.10 PC16:0/20:4 782.56 9.69–14.74 0.634 0.04
PC18:0/22:5 836.61 4.69–8.93 0.733 0.02
PC18:1/18:1 786.59 19.22–34.49 PC16:0/18:1 760.58 147.15–175.04 20.904 ,0.01
PC18:1/18:1 786.59 8.56–15.16 20.833 ,0.01
PlsC18:1/20:2 796.61 1.47–2.56 PlsC16:0/16:1 720.00 1.32–2.67 0.826 ,0.01
PC18:2/20:4 + PC16:0/22:6 806.56 3.42–15.62 PC22:6/22:6 878.56 0.60–3.81 0.683 0.04
PC18:0/20:3 812.61 1.90–4.59 PC18:0/22:5 836.61 4.69–8.93 0.733 0.02
PC18:0/22:6 834.59 1.36–5.67 PC18:1/22:6 832.58 3.41–4.51 0.666 0.04
PC22:6/22:6 878.56 0.60–3.81 0.738 0.01
PC20:6/22:6 850.50 0.09–0.75 PC24:5/22:6 908.60 ,0.01–0.39 0.731 0.01
a: Abbreviations of individual PC and PlsC species are as follows: position on the glycerol backbone as shown as sn-1/sn-2 of the fatty acid and fatty alcohol radicals
(abbreviated as number of carbons: number of double bonds).
doi:10.1371/journal.pone.0035102.t004
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obtained in rat and baboon neonates [33,34] thus confirming _at
least for DHA_ that erythrocyte fatty acid accumulation may be
used as an indicator of their neural accretion. However, this
relationship may be effective only over the time scale that these
experiments were done, corresponding to the period of brain
development. This cautionary note was clearly mentioned in two
of these papers [4,33]. Even if we have obtained our data in non-
supplemented subjects, they seem to corroborate this restrictive
use of red blood cell gas chromatographic profile, at least in old
humans (mean age of 84.3 y). Indeed, our gas chromatography
results have shown that such an association between erythrocytes
and the retina, although existing, was negative (rSpear-
man=20.733, P=0.02). In addition, we have found no other
relevant association between a red blood cell fatty acid and the
corresponding fatty acid in the retina, except for arachidonic acid
(20:4n-6) and the total n-6/n-3 ratio. The conclusions that can be
drawn from these results could be, either that the associations
observed during post-natal development no longer exist in the
adult/elderly, or that they still do exist but they are not visible due
to a global analysis processing. Indeed, gas chromatography
methodology gives the relative abundance of the whole fatty acid
pool in a tissue, independently from their phospholipid origin.
Thus, a more precise approach would consist in LC-ESI-MS
analysis that allows a quantitative evaluation of individual
phospholipid entities in the different lipid fractions where the
differences are likely to be more confirmed. Our results confirm
that LC-ESI-MS would be a more accurate approach since they
have revealed some associations between erythrocyte and ocular
lipids that do not exist through gas chromatography analysis.
The results we have obtained may constitute a basis for future
clinical trials related to lipids or fatty acids in ophthalmology. First,
and as stated above, they may help in preferring the LC-ESI-MS
technology instead of gas chromatography for lipidomic analyses.
In addition, our data outline several circulating markers that can
serve as a surrogate of ocular tissue lipid composition. Such
markers may be useful in a wide range of retinal and/or optic
nerve diseases. Among these different markers, three of them
(namely PlsE18:0/20:4, PE18:0/22:4 and PE18:0/20:4+PE18:0/
22:5) were positively or negatively associated with DHA in retinal
ethanolamine-phospholipids. Retinal DHA is maximally concen-
trated in photoreceptor outer segment membrane phospholipids
where it can represent up to 50% of the total esterified fatty acids
[78,79,80,81]. Within photoreceptor outer segments membranes,
DHA is mostly found in ethanolamine- and less in choline-
phospholipids [7]. As well documented by SanGiovanni and Chew
[48], the functions played by DHA in retinal photoreceptors
appear to be multiple and include a structural role in membranes
and specific interactions with rhodopsin protein, and therefore
influences visual transduction processes. In addition, DHA was
shown to be the precursor of neuroprotectin D1 (NPD1), an
Figure 5. Erythrocyte PC16:0/20:4 as a possible marker of a pool of retinal VLC-PUFA. A): In the retina, VLC-PUFA accounted for about
25% of retinal PC species esterified to DHA, themself representing 11% of retinal total PC and PlsC. B): PC34:6/22:6, PC36:6/22:6, and PC36:5/22:6 were
the longest and the most unsaturated VLC-PUFA in the retina. These three species accounted for 22.7% of total retinal VLC-PUFA. C) This pool of
retinal VLC-PUFA was negatively associated with erythrocyte PC16:0/20:4 (rSpearman=20.783, P=0.01). Abbreviations of individual PC species are as
follows: position on the glycerol backbone as shown as sn-1/sn-2 of the fatty alcohol radicals (abbreviated as number of carbons: number of double
bonds).
doi:10.1371/journal.pone.0035102.g005
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oxygenated derivative synthesized by retinal pigment epithelium
cells that shows potent anti-inflammatory and anti-apoptotic
properties [82]. As reviewed by Bazan [9], a large number of
evidence suggests that the integrity of photoreceptor cells is
dependent at least in part to DHA provided by photoreceptors for
NPD1 biosynthesis in retinal pigment epithelium cells. Such a
metabolism involving DHA in retinal cells may be of great
importance when considering retinal diseases exhibiting photore-
ceptor degeneration such as retinitis pigmentosa or AMD. The
recent discovery of NPD1 and of its functions is very relevant
when regarding other data showing a higher risk of the onset or
progression of AMD in people consuming less DHA or DHA-rich
fish [16,17,18,20,21]. These data are also very consistent with the
finished or ongoing clinical trials aiming to prevent the onset or
delay the progression of AMD through DHA supplementation
[26,28,83,84]. In such studies, one can easily imagine how
interesting would be an indicator of the retinal pool of DHA, in
order to link it to dietary habits (for observation studies) or to a
dietary supplementation (for intervention studies), or in order to
detect potent responders/non responders or compliant/non
compliant subjects within the cohorts. Our results show that
erythrocyte PlsE18:0/20:4, PE18:0/22:4 and PE18:0/
20:4+PE18:0/22:5 would be good indicators since they were
associated to 79% (for PlsE18:0/20:4) and 89% (for PE18:0/22:4
and PE18:0/20:4+PE18:0/22:5) of retinal ethanolamine-phospho-
lipids esterified with DHA, respectively.
The use of PC16:0/20:4 as a marker of VLC-PUFA in choline-
phospholipids may be more limited. Indeed, even if the presence
of VLC-PUFA in human retina is now well documented [40,85],
and the relationships between VLC-PUFA and Stargardt Macular
Dystrophy well established [86,87], the exact functions of these
atypical fatty acids in retinal health are still unknown. Neverthe-
less, PC16:0/20:4 can be used as a research tool at least to confirm
the depletion of retinal VLC-PUFA in human patients or the
efficacy of nutritional and non-nutritional treatments in restoring
retinal VLC-PUFA [28,88,89]. This marker was strongly associ-
ated with retinal VLC-PUFA having the longest carbon-chain
Table 5. Statistically significant associations between erythrocyte and optic nerve individual choline-phospholipid concentrations
evaluated by liquid chromatography coupled with tandem mass spectrometry.
erythrocyte optic nerve
molecular species [M+H]+
range of
concentration
(mg of mg
phospholipids) molecular species [M+H]+
range of
concentration
(mg of mg
phospholipids) rSpearman P
PlsC16:0/16:1a 720.00 1.24–3.48 PlsC18:1/22:1 826.25 0.10–0.24 0.942 ,0.01
PlsC18:1/18:0 772.61 2.74–4.65 PlsC18:1/22:1 826.25 0.10–0.24 0.755 0.01
PlsC18:0/18:0 774.63 2.44–3.99 PlsC18:1/22:1 826.25 0.10–0.24 0.742 0.05
PlsC18:1/20:2 796.61 1.47–2.56 PlsC18:1/18:0 772.61 1.48–3.88 0.942 ,0.01
PC18:0/20:3 812.61 1.90–4.59 PC24:3/22:6 912.60 0.20–1.18 20.773 0.04
PC25:3/22:6 926.70 0.89–2.52 20.788 0.03
PC18:0/20:2 814.60 0.48–1.71 PC22:3/22:6 884.60 0.28–1.15 20.767 0.04
PC22:2/22:6 886.60 0.30–0.76 20.822 0.02
PC24:3/22:6 912.60 0.20–1.18 20.942 ,0.01
PC25:6/22:6 920.60 0.22–1.22 20.837 0.01
PC25:3/22:6 926.70 0.89–2.52 20.942 ,0.01
PlsC18:1/22:4 820.55 0.37–0.80 PlsC18:0/16:1+PlsC16:0/18:1+PlsC18:1/16:0 744.58 1.78–3.22 0.885 0.01
PlsC18:0/22:4 822.55 0.28–0.90 PlsC18:0/16:1+PlsC16:0/18:1+PlsC18:1/16:0 744.58 1.78–3.22 0.828 0.04
PlsC18:1/18:0 772.61 1.48–3.88 0.788 0.03
PlsC18:1/22:4 820.55 0.12–0.35 0.828 0.04
PlsC18:1/22:1 826.25 0.10–0.24 0.828 0.04
PlsC18:1/22:1 826.25 0.08–0.47 PlsC18:1/18:0 772.61 1.48–3.88 0.750 0.05
PlsC18:1/22:4 820.55 0.12–0.35 0.942 ,0.01
PlsC18:1/22:1 826.25 0.10–0.24 0.942 ,0.01
PC18:0/22:5 836.61 0.97–1.76 PC24:3/22:6 912.60 0.20–1.18 0.763 0.04
PC25:3/22:6 926.70 0.89–2.52 0.751 0.05
PC18:0/22:4 838.62 0.36–1.44 PC26:1/22:6 944.70 0.34–0.67 20.885 0.01
PC20:3/22:6+PC20:4/22:5+PC20:5/22:4 856.60 0.04–0.71 PC18:0/22:5 836.61 0.56–1.43 0.784 0.03
PC24:3/22:6 912.60 0.20–1.18 0.847 0.01
PC25:6/22:6 920.60 0.22–1.22 0.942 ,0.01
PC22:6/22:6 878.56 0.11–0.75 PC25:6/22:6 920.60 0.22–1.22 0.828 0.04
a: Abbreviations of individual PC and PlsC species are as follows: position on the glycerol backbone as shown as sn-1/sn-2 of the fatty acid and fatty alcohol radicals
(abbreviated as number of carbons: number of double bonds).
doi:10.1371/journal.pone.0035102.t005
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(namely PC34/6/22:6, PC36:6/22:6 and PC36:5/22:6) (rSpear-
man=20.783, P=0.01).
The data obtained on the optic nerve may be of interest
regarding the pathophysiology of glaucoma. Glaucoma or
glaucomatous optic neuropathy is the leading cause of blindness
worldwide that will affect almost 80 million people in 2020 [13]. It
is characterized by the degeneration of retinal ganglion cells whose
axons form the optic nerve. The clinical diagnosis of glaucoma is
based on the morphologic examination of the optic nerve head
and the measurement of visual fields, meaning that retinal neuron
degeneration has already started at the time of the disease
discovery. This is why the identification of early markers of
glaucoma represents a great challenge in order to apply early
neuroprotection treatments to the optic nerve [90]. The present
data reveal that several phospholipid entities in the optic nerve are
associated with ethanolamine- or choline-phospholipids in red
blood cells. Particularly, PlsE16:0/22:6 and PlsE16:0/22:4 in
erythrocyte were negatively associated with a pool of PlsE species
(namely PlsE18:0/22:5, PlsE16:0/20:3, PlsE16:0/20:4, PlsE18:0/
20:4, and PlsE16:0/22:4, rSpearman=20.988, P,0.001) repre-
senting almost 20% of total optic nerve PlsE. Previous data have
shown that PlsE represent three fourth of total ethanolamine
phospholipids, accounting themselves for 40% of optic nerve
phospholipids [5]. The pool of optic nerve PlsE that is negatively
associated to erythrocyte PlsE16:0/22:6 and PlsE16:0/22:4 would
then represent about 6% of total optic nerve phospholipids. Even
if its representativeness is low, one can imagine that the
concentrations of these molecules would be lowered in conditions
of optic nerve degeneration, making that PlsE16:0/22:6 and
PlsE16:0/22:4 in erythrocytes would represent good candidates to
mirror these changes. The results we have obtained on choline-
phospholipids are exciting regarding one of our previous work
patients with glaucoma [31]. Indeed, we have shown the
occurrence of numerous changes in erythrocyte levels of several
choline-phospholipid species in patients with primary open-angle
glaucoma. Particularly, through linear regression analyses, we
have proposed that the levels of erythrocyte concentrations of total
PlsC species may start to decline about 20 years before the first
clinical signs of glaucoma. Since the data of the present work show
a number of positive associations between circulating and optic
nerve levels of PlsC species, we can imagine a very early loss of
some choline-plasmalogens in the optic nerve of patients with
primary open-angle glaucoma. On the other hand, the positive
associations we have found between erythrocyte levels of PC22:6/
22:6 and PC20:3/22:6 with optic nerve PC25:6/22:6 and
PC24:2/22:6 support the hypothesis of an additional loss of non-
plasmalogen choline-phospholipids esterified with DHA in the
optic nerve during glaucoma [31].
Even if this study has some originality and strength, namely the
unique origin of the samples studied and on the powerful
Table 6. Statistically significant associations between erythrocyte and retinal individual ethanolamine-phospholipid
concentrations evaluated by liquid chromatography coupled with tandem mass spectrometry.
erythrocyte retina
molecular
species
[M+H]+ or MS/MS
transitiona
range of concentration
(mg of mg phospholipids
or ratio to PE14:0/14:0)b
molecular
species [M+H]+
range of concentration
(mg of mg phospholipids
or ratio to PE14:0/14:0)a rSpearman P
PE16:0/16:0c 692.54 0.16–0.55 PE16:0/16:0 692.54 0.03–0.43 0.948 0.05
PE 18:0/18:1 746.59 9.64–19.23 0.948 0.05
PE16:0/18:2 716.54 6.24–9.92 PE 16:0/22:6 764.54 20.22–50.68 0.953 0.04
PE 18:0/22:6 792.57 116.65–294.27 0.948 0.05
PE18:0/18:2 744.57 10.03–13.93 PE 18:1/22:6 790.56 12.83–53.08 0.981 0.02
PE 18:0/22:6 792.57 116.65–294.27 0.982 0.02
PE18:0/18:1 746.59 4.77–8.14 PE 16:0/16:0 692.54 0.03–0.43 0.947 0.05
PE 18:0/18:1 746.59 0.64–19.23 0.956 0.04
PE18:0/22:4 796.60 2.19–3.42 PE 16:0/22:6 764.54 20.22–50.68 0.972 0.03
PE 18:1/22:6 790.56 12.83–53.08 0.977 0.02
PE 18:0/22:6 792.57 116.65–294.27 0.978 0.02
PE18:0/20:4 768.57 19.30–24.47 PE 16:0/22:6 764.54 20.22–50.68 0.948 0.05
PE18:0/22:5 794.59 3.01–5.21 PE 18:1/22:6 790.56 12.83–53.08 0.990 0.01
PE 18:0/22:6 792.57 116.65–294.27 0.993 ,0.01
PE20:1/22:6 818.56 ,0.01–0.84 PE 16:0/22:6 764.54 20.22–50.68 0.978 0.02
PE 18:1/22:6 790.56 12.83–53.08 0.994 ,0.01
PlsE18:0/20:4 750-.303 0.05–0.98 PE18:1/22:6 790.56 12.83–53.08 20.977 0.02
PE18:0/22:6 792.57 116.65–294.27 20.973 0.03
PE20:3/22:6 814.56 1.33–11.50 20.992 ,0.01
Total PlsE - 0.33–6.24 Total PlsE - 1.59–2.15 0.953 0.04
a: [M+H]+ for PE species and MS/MS transition for PlsE species.
b: PE species are expressed as mg of mg of total phospholipids whereas PlsE species are expressed as ratio to the internal standard PE14:0/14:0.
c: Abbreviations of individual PE and PlsE species are as follows: position on the glycerol backbone as shown as sn-1/sn-2 of the fatty acid and fatty alcohol radicals
(abbreviated as number of carbons: number of double bonds).
doi:10.1371/journal.pone.0035102.t006
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Figure 6. Identification of circulating indexes of retinal PE esterified to DHA. A) PE with DHA accounted for 63% of total retinal PE species.
Within these entities, two different pools of molecules were of concern as they represented 79% and 89% of the total PE with 22:6. B) PlsE18:0/20:4 in
erythrocytes was negatively associated to the first group represented by PE18:0/22:6+PE18:1/22:6+PE20:3/22:6 (rSpearman=21.000, P,0.001). C)
The second fraction of retinal PE with 22:6 represented by PE16:0/22:6+PE18:0/22:6+PE18:1/22:6 was positively associated to PE18:0/22:4 (black
circles, rSpearman= 0.950, P= 0.04) and PE18:0/20:4+PE18:0/22:5 (open circles, rSpearman=20.995, P= 0.01) in erythrocytes. Abbreviations of
individual PE species are as follows: position on the glycerol backbone as shown as sn-1/sn-2 of the fatty alcohol radicals (abbreviated as number of
carbons: number of double bonds).
doi:10.1371/journal.pone.0035102.g006
Table 7. Statistically significant associations between erythrocyte and optic nerve individual ethanolamine-phospholipid
concentrations evaluated by liquid chromatography coupled with tandem mass spectrometry.
erythrocyte optic nerve
molecular
species
[M+H]+ or MS/MS
transitiona
range of concentration
(mg of mg phospholipids
or ratio to PE14:0/14:0)b
molecular
species
[M+H]+ or
MS/MS
transitiona
range of concentration
(mg of mg phospholipids
or ratio to PE14:0/14:0)b rSpearman P
PE18:1/
18:1+PE18:0/18:2c
744.57 10.02–13.93 PlsE16:0/20:4 722 -.303 0.10–0.31 20.666 ,0.01
PlsE18:1/20:4 748 -.303 0.32–0.54 20.998 ,0.01
PE18:1/
20:4+PE16:0/22:5
766.56 14.10–20.24 PE16:0/16:1 690.53 0.09–0.83 0.988 0.01
PE16:0/20:4 740.54 1.01–2.64 0.950 0.05
PE18:0/20:4 765.57 14.15–20.76 0.950 0.04
PE18:1/22:6 790.56 1.57–2.76 0.978 0.02
PlsE18:0/22:5 776 -.329 0.05–0.06 20.974 0.02
PE18:0/20:4 768.57 19.30–24.47 PlsE18:1/22:4 776 -.331 0.74–1.11 20.943 0.05
PE18:0/22:6 792.57 2.36–7.47 PE18:1/22:6 790.56 1.57–2.76 0.948 0.04
PE20:0/
20:3+PE22:1/18:2
798.62 ,0.01–0.13 PlsE18:0/22:6 774 -.327 0.04–0.05 20.944 0.05
PlsE18:0/22:5 776 -.329 0.05–0.06 20.953 0.04
PlsE16:0/22:6 746 -.327 ,0.01–0.02 PlsE16:0/20:3 724 -.305 0.05–0.09 0.874 0.05
PlsE16:0/22:4 750 -.331 0.39–0.59 0.930 0.02
PlsE16:0/22:4 750 -.331 ,0.01–0.36 PlsE16:0/20:4 722 -.303 0.10–0.31 20.999 ,0.01
PlsE18:1/20:4 748 -.303 0.32–0.54 0.999 ,0.01
PlsE18:1/22:6 772 -.327 ,0.01–0.01 20.988 0.01
PlsE18:0/22:5 776 -.329 0.05–0.06 0.970 0.03
PlsE18:0/20:4 750 -.303 0.05–0.98 PE18:1/22:6 790.56 1.57–2.76 0.962 0.03
a: [M+H]+ for PE species and MS/MS transition for PlsE species.
b: PE species are expressed as mg of mg of total phospholipids whereas PlsE species are expressed as ratio to the internal standard PE14:0/14:0.
c: Abbreviations of individual PE and PlsE species are as follows: position on the glycerol backbone as shown as sn-1/sn-2 of the fatty acid and fatty alcohol radicals
(abbreviated as number of carbons: number of double bonds).
doi:10.1371/journal.pone.0035102.t007
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analytical methodology, it has several distinct limitations. The
principal weakness is the low number of subjects included in the
study. This is why the associations we have found do not point out
any definitive marker of tissue composition but give a list of
potential good candidates susceptible to play this role. Similar
analyses should be done in a larger number of subjects including
individuals known to be affected by the degenerative ophthalmic
diseases mentioned in the present paper. It would be also
interesting to enlarge the future analyzes to other molecules, and
particularly to markers of lipid peroxidation such as Amadori–PE
[91,92], 4-hydroxynonenal, 4-hydroxyhexenal, isoprostanes, and
neuroprostanes [93,94,95], as they could represent biomarkers of
the disease state of the retina. However, and accounting to the
expected demographic forecasts estimating that patients with eye
diseases are expected to represent a sensitive and growing socio-
economic burden in the next future, these results may be of
importance when considering the increasing number of human
studies related to lipids and ophthalmic diseases.
Supporting Information
Table S1 Complete composition in individual species of
phosphatidyl-choline (PC) and plasmenyl-choline (PlsC)
of erythrocytes, retinas and optic nerves issued from
human donors.
(DOC)
Table S2 Complete composition in individual species of
phosphatidyl-ethanolamine (PE) and plasmenyl- etha-
nolamine (PlsE) of erythrocytes, retinas and optic nerves
issued from human donors.
(DOC)
Author Contributions
Conceived and designed the experiments: NA GT PG CPCG AMB LB.
Performed the experiments: OB GT SG LM SC. Analyzed the data: OB
SG SC. Contributed reagents/materials/analysis tools: OB SG SC. Wrote
the paper: NA OB GT PG CPCG AMB LB.
References
1. Martinez M (1992) Tissue levels of polyunsaturated fatty acids during early
human development. J Pediatr 120: S129–138.
2. Martinez M, Ballabriga A, Gil-Gibernau JJ (1988) Lipids of the developing
human retina: I. Total fatty acids, plasmalogens, and fatty acid composition of
ethanolamine and choline phosphoglycerides. J Neurosci Res 20: 484–490.
3. Sastry PS (1985) Lipids of nervous tissue: composition and metabolism. Prog
Lipid Res 24: 69–176.
4. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA (1994) Fatty
acid composition of brain, retina, and erythrocytes in breast- and formula-fed
infants. Am J Clin Nutr 60: 189–194.
5. Das SK, Steen ME, McCullough MS, Bhattacharyya DK (1978) Composition of
lipids of bovine optic nerve. Lipids 13: 679–684.
6. Greiner CA, Greiner JV, Leahy CD, Auerbach DB, Marcus MD, et al. (1995)
Distribution of membrane phospholipids in the rabbit neural retina, optic nerve
head and optic nerve. Int J Biochem Cell Biol 27: 21–28.
7. Fliesler SJ, Anderson RE (1983) Chemistry and metabolism of lipids in the
vertebrate retina. Prog Lipid Res 22: 79–131.
8. Litman BJ, Mitchell DC (1996) A role for phospholipid polyunsaturation in
modulating membrane protein function. Lipids 31 Suppl: S193–197.
9. Bazan NG (2007) Homeostatic regulation of photoreceptor cell integrity:
significance of the potent mediator neuroprotectin D1 biosynthesized from
docosahexaenoic acid: the Proctor Lecture. Invest Ophthalmol Vis Sci 48:
4866–4881.
10. Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions. Prog
Lipid Res 40: 199–229.
11. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP (2003) Age-related
macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv
Ophthalmol 48: 257–293.
12. Jacobson SG, Cideciyan AV (2010) Treatment possibilities for retinitis
pigmentosa. N Engl J Med 363: 1669–1671.
13. Quigley HA, Broman AT (2006) The number of people with glaucoma
worldwide in 2010 and 2020. Br J Ophthalmol 90: 262–267.
14. Kashiwagi K, Okubo T, Tsukahara S (2004) Association of magnetic resonance
imaging of anterior optic pathway with glaucomatous visual field damage and
optic disc cupping. J Glaucoma 13: 189–195.
15. Lagreze WA, Gaggl M, Weigel M, Schulte-Monting J, Buhler A, et al. (2009)
Retrobulbar optic nerve diameter measured by high-speed magnetic resonance
imaging as a biomarker for axonal loss in glaucomatous optic atrophy. Invest
Ophthalmol Vis Sci 50: 4223–4228.
16. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, et al. (2001) Prospective
study of dietary fat and the risk of age-related macular degeneration. Am J Clin
Nutr 73: 209–218.
Figure 7. PlsE16:0/22:6 and PlsE16:0/22:4 as indexes of a pool of optic nerve PlsE. A) PlsE18:0/22:5, PlsE16:0/20:3, PlsE16:0/20:4, PlsE18:0/
20:4, and PlsE16:0/22:4 represented 19% of optic nerve PlsE. B) This group of optic nerve PlsE was negatively associated to PlsE16:0/22:6 and PlsE16:0/
22:4 in erythrocytes (rSpearman=20.988, P,0.001). Abbreviations of individual PlsE species are as follows: position on the glycerol backbone as
shown as sn-1/sn-2 of the fatty alcohol radicals (abbreviated as number of carbons: number of double bonds).
doi:10.1371/journal.pone.0035102.g007
Circulating Biomarkers of Ocular Lipids in Human
PLoS ONE | www.plosone.org 16 April 2012 | Volume 7 | Issue 4 | e35102
17. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, et al. (2001)
Dietary fat and risk for advanced age-related macular degeneration. Arch
Ophthalmol 119: 1191–1199.
18. Seddon JM, Cote J, Rosner B (2003) Progression of age-related macular
degeneration: association with dietary fat, transunsaturated fat, nuts, and fish
intake. Arch Ophthalmol 121: 1728–1737.
19. Seddon JM, George S, Rosner B (2006) Cigarette smoking, fish consumption,
omega-3 fatty acid intake, and associations with age-related macular
degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch
Ophthalmol 124: 995–1001.
20. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL, 3rd, et al.
(2007) The relationship of dietary lipid intake and age-related macular
degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol
125: 671–679.
21. SanGiovanni JP, Chew EY, Agron E, Clemons TE, Ferris FL, 3rd, et al. (2008)
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake
with incident age-related macular degeneration: AREDS report no. 23. Arch
Ophthalmol 126: 1274–1279.
22. Simonelli F, Manna C, Romano N, Nunziata G, Voto O, et al. (1996)
Evaluation of fatty acids in membrane phospholipids of erythrocytes in retinitis
pigmentosa patients. Ophthalmic Res 28: 93–98.
23. Hoffman DR, Uauy R, Birch DG (1993) Red blood cell fatty acid levels in
patients with autosomal dominant retinitis pigmentosa. Exp Eye Res 57:
359–368.
24. Hoffman DR, Uauy R, Birch DG (1995) Metabolism of omega-3 fatty acids in
patients with autosomal dominant retinitis pigmentosa. Exp Eye Res 60:
279–289.
25. Hoffman DR, Birch DG (1995) Docosahexaenoic acid in red blood cells of
patients with X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 36:
1009–1018.
26. Hubbard LD, Danis RP, Neider MW, Thayer DW, Wabers HD, et al. (2008)
Brightness, contrast, and color balance of digital versus film retinal images in the
age-related eye disease study 2. Invest Ophthalmol Vis Sci 49: 3269–3282.
27. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, et al. (2004) A
randomized, placebo-controlled clinical trial of docosahexaenoic acid supple-
mentation for X-linked retinitis pigmentosa. Am J Ophthalmol 137: 704–718.
28. Querques G, Benlian P, Chanu B, Portal C, Coscas G, et al. (2009) Nutritional
AMD treatment phase I (NAT-1): feasibility of oral DHA supplementation in
age-related macular degeneration. Eur J Ophthalmol 19: 100–106.
29. Blodi BA (2004) Nutritional supplements in the prevention of age-related
macular degeneration. Insight 29: 15–16; quiz 17–18.
30. Ren H, Magulike N, Ghebremeskel K, Crawford M (2006) Primary open-angle
glaucoma patients have reduced levels of blood docosahexaenoic and
eicosapentaenoic acids. Prostaglandins Leukot Essent Fatty Acids 74: 157–163.
31. Acar N, Berdeaux O, Juaneda P, Gregoire S, Cabaret S, et al. (2009) Red blood
cell plasmalogens and docosahexaenoic acid are independently reduced in
primary open-angle glaucoma. Exp Eye Res 89: 840–853.
32. Farquhar JW (1962) Human erythrocyte phosphoglycerides. I. Quantification of
plasmalogens, fatty acids and fatty aldehydes. Biochim Biophys Acta 60: 80–89.
33. Carlson SE, Carver JD, House SG (1986) High fat diets varying in ratios of
polyunsaturated to saturated fatty acid and linoleic to linolenic acid: a
comparison of rat neural and red cell membrane phospholipids. J Nutr 116:
718–725.
34. Sarkadi-Nagy E, Wijendran V, Diau GY, Chao AC, Hsieh AT, et al. (2004)
Formula feeding potentiates docosahexaenoic and arachidonic acid biosynthesis
in term and preterm baboon neonates. J Lipid Res 45: 71–80.
35. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation
and purification of total lipids from animal tissues. J Biol Chem 226: 497–509.
36. Moilanen T, Nikkari T (1981) The effect of storage on the fatty acid composition
of human serum. Clin Chim Acta 114: 111–116.
37. Juaneda P, Rocquelin G (1985) Rapid and convenient separation of
phospholipids and non phosphorus lipids from rat heart using silica cartridges.
Lipids 20: 40–41.
38. Morrison WR, Smith LM (1964) Preparation of fatty acid methyl esters and
dimethylacetals from lipids with boron fluoride methanol. J Lipid Res 53:
600–608.
39. Bartlett EM, Lewis DH (1970) Spectrophotometric determination of phosphate
esters in the presence and absence of orthophosphate. Anal Biochem 36:
159–167.
40. Berdeaux O, Juaneda P, Martine L, Cabaret S, Bretillon L, et al. (2010)
Identification and quantification of phosphatidylcholines containing very long
chain polyunsaturated fatty acid (VLC-PUFA) in bovine and human retina by
liquid chromatography/tandem mass spectrometry. J Chromatogr A 1217:
7738–7748.
41. Ahn EJ, Kim H, Chul Chung B, Kong G, Moon MH (2008) Quantitative
profiling of phosphatidylcholine and phosphatidyletahnolamine in a steatosis/
fibrosis model of rat liver by nanoflow liquid chromatography/tandem mass
spectrometry. Journal of Chromatography A 1194: 90–102.
42. Brugger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD (1997)
Quantitative analysis of biological membrane lipids at the low picomole level
by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad
Sci U S A 94: 2339–2344.
43. Koivusalo M, Haimi P, Heikinheimo L, Kostiainen R, Somerharju P (2001)
Quantitative determination of phospholipid compositions by ESI-MS: effects of
acyl chain length, unsaturation, and lipid concentration on instrument response.
J Lipid Res 42: 663–672.
44. Delong CJ, Baker PR, Samuel M, Cui Z, Thomas MJ (2001) Molecular species
composition of rat liver phospholipids by ESI-MS/MS: the effect of
chromatography. J Lipid Res 42: 1959–1968.
45. Berry KZ, Murphy RC (2004) Electrospray ionization tandem mass spectrom-
etry of glycerophosphoethanolamine plasmalogen phospholipids. J of American
Society for Mass Spectrometry 15: 1499–1508.
46. Bretillon L, Thuret G, Gregoire S, Acar N, Joffre C, et al. (2008) Lipid and fatty
acid profile of the retina, retinal pigment epithelium/choroid, and the lacrimal
gland, and associations with adipose tissue fatty acids in human subjects. Exp
Eye Res 87: 521–528.
47. Acar N, Gregoire S, Andre A, Juaneda P, Joffre C, et al. (2007) Plasmalogens in
the retina: in situ hybridization of dihydroxyacetone phosphate acyltransferase
(DHAP-AT)–the first enzyme involved in their biosynthesis–and comparative
study of retinal and retinal pigment epithelial lipid composition. Exp Eye Res 84:
143–151.
48. SanGiovanni JP, Chew EY (2005) The role of omega-3 long-chain polyunsat-
urated fatty acids in health and disease of the retina. Prog Retin Eye Res 24:
87–138.
49. Stillwell W, Wassall SR (2003) Docosahexaenoic acid: membrane properties of a
unique fatty acid. Chem Phys Lipids 126: 1–27.
50. Calder PC (2009) Polyunsaturated fatty acids and inflammatory processes: New
twists in an old tale. Biochimie 91: 791–795.
51. Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133 Suppl 3:
925S–932S.
52. Baylin A, Campos H (2006) The use of fatty acid biomarkers to reflect dietary
intake. Curr Opin Lipidol 17: 22–27.
53. Hodson L, Skeaff CM, Fielding BA (2008) Fatty acid composition of adipose
tissue and blood in humans and its use as a biomarker of dietary intake. Prog
Lipid Res 47: 348–380.
54. Lands WE (1995) Long-term fat intake and biomarkers. Am J Clin Nutr 61:
721S–725S.
55. Barrows BR, Parks EJ (2006) Contributions of different fatty acid sources to very
low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin
Endocrinol Metab 91: 1446–1452.
56. Chong MF, Hodson L, Bickerton AS, Roberts R, Neville M, et al. (2008) Parallel
activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d
of high-carbohydrate feeding. Am J Clin Nutr 87: 817–823.
57. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, et al. (1996)
Human fatty acid synthesis is stimulated by a eucaloric low fat, high
carbohydrate diet. J Clin Invest 97: 2081–2091.
58. Timlin MT, Parks EJ (2005) Temporal pattern of de novo lipogenesis in the
postprandial state in healthy men. Am J Clin Nutr 81: 35–42.
59. Antonis A, Bersohn I (1962) The influence of diet on fecal lipids in South African
white and Bantu prisoners. Am J Clin Nutr 11: 142–155.
60. Bhattacharyya AK, Malcom GT, Guzman MA, Kokatnur MG, Oalmann MC,
et al. (1987) Differences in adipose tissue fatty acid composition between black
and white men in New Orleans. Am J Clin Nutr 46: 41–46.
61. Crowe FL, Skeaff CM, Green TJ, Gray AR (2008) Serum n-3 long-chain PUFA
differ by sex and age in a population-based survey of New Zealand adolescents
and adults. Br J Nutr 99: 168–174.
62. Holman RT, Smythe L, Johnson S (1979) Effect of sex and age on fatty acid
composition of human serum lipids. Am J Clin Nutr 32: 2390–2399.
63. Nikolaidis MG, Mougios V (2004) Effects of exercise on the fatty-acid
composition of blood and tissue lipids. Sports Med 34: 1051–1076.
64. Pawlosky RJ, Hibbeln JR, Salem N, Jr. (2007) Compartmental analyses of
plasma n-3 essential fatty acids among male and female smokers and
nonsmokers. J Lipid Res 48: 935–943.
65. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, et al. (2002)
Blood levels of long-chain n-3 fatty acids and the risk of sudden death.
N Engl J Med 346: 1113–1118.
66. Smedman AE, Gustafsson IB, Berglund LG, Vessby BO (1999) Pentadecanoic
acid in serum as a marker for intake of milk fat: relations between intake of milk
fat and metabolic risk factors. Am J Clin Nutr 69: 22–29.
67. Ebaugh FG, Jr., Emerson CP, Ross JF (1953) The use of radioactive chromium
51 as an erythrocyte tagging agent for the determination or red cell survival in
vivo. J Clin Invest 32: 1260–1276.
68. Brown AJ, Pang E, Roberts DC (1991) Erythrocyte eicosapentaenoic acid versus
docosahexaenoic acid as a marker for fish and fish oil consumption.
Prostaglandins Leukot Essent Fatty Acids 44: 103–106.
69. Di Marino L, Maffettone A, Cipriano P, Sacco M, Di Palma R, et al. (2000) Is
the erythrocyte membrane fatty acid composition a valid index of skeletal muscle
membrane fatty acid composition? Metabolism 49: 1164–1166.
70. Rodriguez Y, Christophe AB (2004) Effect of diabetes mellitus and different
treatments on plasma and erythrocyte phospholipid fatty acid composition in
type 2 diabetics. Ann Nutr Metab 48: 335–342.
71. Rodriguez-Palmero M, Lopez-Sabater MC, Castellote-Bargallo AI, de la Torre-
Boronat MC, Rivero-Urgell M (1997) Administration of low doses of fish oil
derived N-3 fatty acids to elderly subjects. Eur J Clin Nutr 51: 554–560.
72. Romon M, Nuttens MC, Theret N, Delbart C, Lecerf JM, et al. (1995)
Comparison between fat intake assessed by a 3-day food record and
phospholipid fatty acid composition of red blood cells: results from the
Monitoring of Cardiovascular Disease-Lille Study. Metabolism 44: 1139–1145.
Circulating Biomarkers of Ocular Lipids in Human
PLoS ONE | www.plosone.org 17 April 2012 | Volume 7 | Issue 4 | e35102
73. Sanders TA, Vickers M, Haines AP (1981) Effect on blood lipids and
haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and
docosahexaenoic acids, in healthy young men. Clin Sci (Lond) 61: 317–324.
74. Tynan MB, Nicholls DP, Maguire SM, Steele IC, McMaster C, et al. (1995)
Erythrocyte membrane fatty acid composition as a marker of dietary compliance
in hyperlipidaemic subjects. Atherosclerosis 117: 245–252.
75. Vicario IM, Malkova D, Lund EK, Johnson IT (1998) Olive oil supplementation
in healthy adults: effects in cell membrane fatty acid composition and platelet
function. Ann Nutr Metab 42: 160–169.
76. Birch EE, Birch DG, Hoffman DR, Uauy R (1992) Dietary essential fatty acid
supply and visual acuity development. Invest Ophthalmol Vis Sci 33:
3242–3253.
77. Uauy RD, Birch DG, Birch EE, Tyson JE, Hoffman DR (1990) Effect of dietary
omega-3 fatty acids on retinal function of very-low-birth-weight neonates.
Pediatr Res 28: 485–492.
78. Neuringer M, Anderson GJ, Connor WE (1988) The essentiality of n-3 fatty
acids for the development and function of the retina and brain. Annu Rev Nutr
8: 517–541.
79. Aveldano MI (1988) Phospholipid species containing long and very long
polyenoic fatty acids remain with rhodopsin after hexane extraction of
photoreceptor membranes. Biochemistry 27: 1229–1239.
80. Gordon WC, Bazan NG (1993) Visualization of [3H]docosahexaenoic acid
trafficking through photoreceptors and retinal pigment epithelium by electron
microscopic autoradiography. Invest Ophthalmol Vis Sci 34: 2402–2411.
81. Gordon WC, Bazan NG (1990) Docosahexaenoic acid utilization during rod
photoreceptor cell renewal. J Neurosci 10: 2190–2202.
82. Bazan NG (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that
protects brain and retina against cell injury-induced oxidative stress. Brain
Pathol 15: 159–166.
83. Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, et al.
(2011) Reducing the genetic risk of age-related macular degeneration with
dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch
Ophthalmol 129: 758–766.
84. Huang LL, Coleman HR, Kim J, de Monasterio F, Wong WT, et al. (2008) Oral
supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated
fatty acids in persons aged 60 years or older, with or without AMD. Invest
Ophthalmol Vis Sci 49: 3864–3869.
85. Brush RS, Tran JT, Henry KR, McClellan ME, Elliott MH, et al. (2010) Retinal
sphingolipids and their very-long-chain fatty acid-containing species. Invest
Ophthalmol Vis Sci 51: 4422–4431.
86. Agbaga MP, Brush RS, Mandal MN, Elliott MH, Al-Ubaidi MR, et al. (2010)
Role of Elovl4 protein in the biosynthesis of docosahexaenoic acid. Adv Exp
Med Biol 664: 233–242.
87. Agbaga MP, Brush RS, Mandal MN, Henry K, Elliott MH, et al. (2008) Role of
Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very
long chain fatty acids. Proc Natl Acad Sci U S A 105: 12843–12848.
88. Liu MM, Tuo J, Chan CC (2011) Gene therapy for ocular diseases.
Br J Ophthalmol 95: 604–612.
89. MacDonald IM, Hebert M, Yau RJ, Flynn S, Jumpsen J, et al. (2004) Effect of
docosahexaenoic acid supplementation on retinal function in a patient with
autosomal dominant Stargardt-like retinal dystrophy. Br J Ophthalmol 88:
305–306.
90. Knepper PA, Samples JR, Yue BYJT (2010) Biomarkers of primary open-angle
glaucoma. Exp Rev Ophthalmol 5: 731–742.
91. Nakagawa K, Oak JH, Higuchi O, Tsuzuki T, Oikawa S, et al. (2005) Ion-trap
tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanol-
amine in human plasma with or without diabetes. J Lipid Res 46: 2514–2524.
92. Shoji N, Nakagawa K, Asai A, Fujita I, Hashiura A, et al. (2010) LC-MS/MS
analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines
in human erythrocytes and blood plasma. J Lipid Res 51: 2445–2453.
93. Arneson KO, Roberts LJ, 2nd (2007) Measurement of products of docosahex-
aenoic acid peroxidation, neuroprostanes, and neurofurans. Methods Enzymol
433: 127–143.
94. Basu S (2010) Fatty acid oxidation and isoprostanes: oxidative strain and
oxidative stress. Prostaglandins Leukot Essent Fatty Acids 82: 219–225.
95. Reed TT (2011) Lipid peroxidation and neurodegenerative disease. Free Radic
Biol Med 51: 1302–1319.
Circulating Biomarkers of Ocular Lipids in Human
PLoS ONE | www.plosone.org 18 April 2012 | Volume 7 | Issue 4 | e35102
